Monthly Update6 Apr 2026, 12:16 pm
Venmax Drugs and Pharmaceuticals: Promoters Confirm No Encumbrance on Shares for FY2026
AI Summary
Venmax Drugs and Pharmaceuticals Ltd. has disclosed an annual declaration from its promoters under Regulation 31(4) of SEBI (SAST) Regulations, 2011. The promoters have confirmed that they have not made any encumbrance, directly or indirectly, on the shares held in the company for the financial year ended March 31, 2026. This disclosure was made to the Assistant General Manager, Chairman of the Department of Corporate Services Audit Committee, and the Bombay Stock Exchange.
Key Highlights
- Venmax Drugs and Pharmaceuticals Ltd. discloses annual declaration from promoters.
- Promoters confirm no encumbrance on shares for the financial year ending March 31, 2026.
- Disclosure made to Assistant General Manager, Chairman of Department of Corporate Services Audit Committee, and Bombay Stock Exchange.
Price Impact
More from VENMAX